Orphan Drugs & Rare Diseases
Moderna and Recordati Form Strategic Alliance to Commercialize mRNA Therapy for Propionic Acidemia
2026-02-04
From CRISPR to National Security: How Rare Diseases Became America’s Next Strategic Industry
2026-02-03
Sanofi’s Venglustat Demonstrates Superiority Over ERT in Phase 3 Type 3 Gaucher Disease Trial
2026-02-02
[Illustrations] The Global and Taiwan Orphan Drug Market Heads Into 2026 With New Rules, New Prices, and New Pressure Points
2026-01-29
LATEST
Ouster Completes Acquisition of StereoLabs to Advance Physical AI Sensing and Perception Technology
2026-02-09
Adyen and Uber Expand Partnership to Launch Kiosks and Enhance Payment Solutions in Emerging Markets
2026-02-09



